Latest 10-K annual reports

American Battery Materials Inc. reported a significant net loss and working capital deficit for fiscal year 2025, raising substantial doubt about its ability to continue as a going concern.

ACCESS Newswire Inc. reported a net income of $4.291 million for 2025, driven by the sale of its Compliance business, despite a slight revenue decrease in continuing operations.

Research Frontiers Incorporated filed an amendment to its annual report to include its Executive Compensation Recovery (Clawback) Policy, mandated by SEC and NASDAQ rules.

Solid Biosciences reports positive interim clinical data for SGT-003 in Duchenne, initiates Phase 3, and secures significant financing to extend its cash runway into mid-2028.

Sky Harbour Group Corporation reported a significant increase in revenue for fiscal year 2025, achieving positive net income driven by operational expansion and non-operating gains, despite rising expenses and a worsening operating loss.

Damora Therapeutics' 2025 annual report details a strategic pivot to mutCALR MPN therapies, significant capital raises, and ongoing preclinical development amidst substantial operating losses.

Tecogen Inc. saw product revenue more than double in 2025, driven by chiller sales, but overall net loss widened significantly to $8.25 million, impacted by increased operating expenses and goodwill impairment.

Larimar Therapeutics reports significant progress in its nomlabofusp clinical program for Friedreich's ataxia, including positive OL study data and key regulatory designations, while securing $107.6 million in new funding.

Aveanna Healthcare Holdings Inc. reported a significant turnaround in net income for fiscal year 2025, driven by robust revenue growth across all segments and strategic acquisitions, despite ongoing regulatory and labor challenges.

Destination XL Group, Inc. reported a net loss of $35.9 million for fiscal 2025 on declining sales, while advancing its proposed merger with FullBeauty Brands and strategic initiatives.

The Credit-Enhanced CorTS Trust For Aon Capital A filed its annual 10-K, confirming compliance and detailing a Dodd-Frank clawback policy for its non-operating structure.

The CorTS Trust for PECO Energy Capital Trust III filed its annual 10-K report for 2025, confirming compliance and the adoption of Dodd-Frank clawback provisions.

Tejon Ranch Co. reports a significant drop in 2025 net income to $75,000, down from $2.69 million in 2024, despite growth in commercial/industrial real estate and multifamily leasing.

Heritage Insurance Holdings, Inc. filed an amended annual report for 2025, primarily to include the auditor's report date, while showcasing significant improvements in net income and operating results.

Blue Biofuels, Inc. completed pilot plant optimization and is ready for commercial production, but reported a significant net loss and requires substantial project financing.

LiqTech International, Inc. filed an amendment to its 2025 Annual Report on Form 10-K, primarily updating information on directors, executive compensation, and corporate governance.

Movado Group, Inc. announced a significant increase in operating and net income for fiscal year 2026, alongside the successful remediation of a material internal control weakness.

EquipmentShare.com Inc reported significant revenue and net income growth in 2025, driven by expansion of its T3 platform and nationwide branch network, following a successful IPO in early 2026.

Plumas Bancorp reported a 4% increase in net income to $29.6 million for 2025, driven by the acquisition of Cornerstone Community Bancorp and strategic asset restructuring.

Mereo BioPharma Group PLC reported its 2025 annual results, revealing Setrusumab's Phase 3 trials for Osteogenesis Imperfecta failed primary fracture reduction endpoints, alongside continued operating losses and a Nasdaq minimum bid price non-compliance notice.

Taysha Gene Therapies reports positive clinical data for TSHA-102 in Rett syndrome, progresses pivotal trials, and extends its cash runway into 2028 through recent capital raises.

Signet Jewelers delivered a significant financial turnaround in Fiscal 2026 with positive sales growth, substantially increased operating income, and a raised dividend, driven by its 'Grow Brand Love' strategy.

Mount Logan Capital Inc. reported a substantial net loss of $60.8 million in 2025, driven by goodwill impairment and transaction costs, despite strategic acquisitions and capital market activities.

Galera Therapeutics reports a significant net income of $149 million for 2025, driven by asset sales and a strategic pivot to advanced breast cancer therapies after divesting its dismutase mimetics portfolio.

Acrivon Therapeutics' 2025 annual report details significant clinical advancements for its oncology pipeline, including positive interim data for ACR-368 in endometrial cancer and progress for ACR-2316, alongside continued operating losses and a need for future funding.

Neuraxis, Inc. reported increased net sales for 2025, driven by product adoption, but continues to face substantial operating losses and going concern doubts.

Chicago Atlantic BDC (LIEN) announced significant portfolio growth and a 250% increase in net investment income for 2025, driven by its focus on cannabis and middle-market lending.

Aebi Schmidt Holding AG reports a 41% sales increase to $1.53 billion in 2025, primarily driven by the Shyft Group acquisition, despite a significant drop in net income and identified material weaknesses in internal controls.

Pelthos Therapeutics Inc. reports a net loss of $43.3 million for 2025, driven by commercialization efforts for ZELSUVMI and recent acquisitions of XEPI and XEGLYZE, while securing $30 million in new financing.

Lithium Americas Corp. reports significant progress on its Thacker Pass project, securing substantial funding and advancing construction towards a late 2027 mechanical completion target.